133 related articles for article (PubMed ID: 28891625)
1. [Effect of Fuzheng Huayu capsule on serum metabolomics in rats with liver fibrosis induced by dimethylnitrosamine].
Gao GY; Zheng XY; Peng Y; Tao YY; Liu P; Yang T; Liu CH
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(9):1725-1731. PubMed ID: 28891625
[TBL] [Abstract][Full Text] [Related]
2. Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang.
Zhang H; Wang X; Hu P; Zhou W; Zhang M; Liu J; Wang Y; Liu P; Luo G
Molecules; 2016 Jan; 21(1):E126. PubMed ID: 26805802
[TBL] [Abstract][Full Text] [Related]
3. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
Song YN; Zhang GB; Lu YY; Chen QL; Yang L; Wang ZT; Liu P; Su SB
J Ethnopharmacol; 2016 Aug; 189():148-56. PubMed ID: 27196295
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and Therapeutic Effects of Fuzheng Huayu Capsule on Liver Fibrosis and Expression of Connective Tissue Growth Factor in Rats].
Chen H; Yang BW; Yuan M; Tang H; Bai L; Liu C; He M; Wang LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):197-202. PubMed ID: 27263294
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Zheng TH; Tao YY; Liu CH
J Ethnopharmacol; 2015 May; 166():305-12. PubMed ID: 25794805
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule.
Wang G; Li Z; Li H; Li L; Li J; Yu C
Molecules; 2016 May; 21(6):. PubMed ID: 27248993
[TBL] [Abstract][Full Text] [Related]
7. [Effect of fuzheng huayu recipe and huangqi tang on DMN-induced experimental liver cirrhosis in rats].
Wang L; Yan X; Zeng Z; Lv J; Liu P; Liu C
Zhongguo Zhong Yao Za Zhi; 2010 Jul; 35(13):1740-4. PubMed ID: 20862970
[TBL] [Abstract][Full Text] [Related]
8. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.
Li XM; Peng JH; Sun ZL; Tian HJ; Duan XH; Liu L; Ma X; Feng Q; Liu P; Hu YY
Acta Pharmacol Sin; 2016 Jun; 37(6):783-93. PubMed ID: 27133300
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Wang CH; Tao YY; Zhou H; Liu CH
J Pharm Biomed Anal; 2015 Oct; 114():152-8. PubMed ID: 26048667
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of endogenous bile acids: a novel method to assess hepatoprotective effect of Tanreqing capsule on carbon-tetrachloride-induced liver injury in rats.
Xu Y; Zhong PP; Tao YY
Chin J Nat Med; 2018 Apr; 16(4):271-283. PubMed ID: 29703327
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Fuzheng Huayu recipe on renal toxic interstitial fibrosis in rats].
Jiang ZH; Cui HY; Liu CH; Liu C; Liu P; Xu LM; Hu YY; Yuan JL; Li FH
Zhong Xi Yi Jie He Xue Bao; 2004 Sep; 2(5):358-60. PubMed ID: 15383259
[TBL] [Abstract][Full Text] [Related]
12. Effects of Shu Gan Jian Pi formula on rats with carbon tetrachloride‑induced liver fibrosis using serum metabonomics based on gas chromatography‑time of flight mass spectrometry.
Jiang H; Qin XJ; Li WP; Ma R; Wang T; Li ZQ
Mol Med Rep; 2017 Oct; 16(4):3901-3909. PubMed ID: 29067456
[TBL] [Abstract][Full Text] [Related]
13. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
Hu YY; Liu P; Liu C
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
[TBL] [Abstract][Full Text] [Related]
14. Serum metabonomics study of the hepatoprotective effect of amarogentin on CCl
Zhang Y; Zhang M; Li H; Zhao H; Wang F; He Q; Zhang T; Wang S
J Pharm Biomed Anal; 2018 Feb; 149():120-127. PubMed ID: 29112900
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.
Yang T; Shen DP; Wang QL; Tao YY; Liu CH
J Ethnopharmacol; 2013 Jul; 148(2):691-700. PubMed ID: 23707207
[TBL] [Abstract][Full Text] [Related]
16. Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.
Yang T; Zheng TH; Zhao Q; Liu W; Li SP; Tao YY; Wang CH; Liu CH
Pharm Biol; 2020 Dec; 58(1):1-7. PubMed ID: 31847670
[No Abstract] [Full Text] [Related]
17. [Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis].
Ge XJ; Zhao CQ; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):834-840. PubMed ID: 29325277
[No Abstract] [Full Text] [Related]
18. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats.
Hu XQ; Song YN; Wu R; Cai FF; Zhang Y; Peng JH; Hu YY; Su SB
J Ethnopharmacol; 2019 Jun; 238():111888. PubMed ID: 31004725
[TBL] [Abstract][Full Text] [Related]
19. Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis.
Zhang B; Hu M; Huang L; Pu Y; Pei H; Hua Z; Yao S
Exp Ther Med; 2014 Oct; 8(4):1123-1126. PubMed ID: 25187808
[TBL] [Abstract][Full Text] [Related]
20. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
